License and Patent Agreements - Additional Information (Detail) CAD in Thousands	1 Months Ended		12 Months Ended
	Jun. 30, 2014 shares	Aug. 31, 2009 CAD	Dec. 31, 2015 CAD	Dec. 31, 2015 USD ($)	Dec. 31, 2014 CAD	Dec. 31, 2013 CAD	Dec. 31, 2015 USD ($)
Patent Licenses [Line Items]
Amount of development milestones payment | $							$ 2,160,000
Biolipox AB [Member]
Patent Licenses [Line Items]
Amount of development milestones payment		CAD 3,000
License fee		50
Value of exchangeable shares issued for license fee		250
Additional milestone payment payable		CAD 1,500
Royalty payments | $				$ 0
Biolipox AB [Member] | Goods and Services Exchanged for Equity Instrument [Member]
Patent Licenses [Line Items]
Number of common stock issued for payment for achievement of milestone | shares	19,762
SHIP1 Product Candidates [Member]
Patent Licenses [Line Items]
License agreement, maintenance fees			CAD 1		CAD 1
SHIP1 Product Candidates [Member] | First Drug Product [Member]
Patent Licenses [Line Items]
Amount of development milestones payment			2,200
SHIP1 Product Candidates [Member] | Subsequent Drug Product [Member]
Patent Licenses [Line Items]
Amount of development milestones payment			1,500
SHIP1 Enzyme and Screening of Product Candidates [Member]
Patent Licenses [Line Items]
License agreement, maintenance fees			CAD 5		CAD 5	CAD 5
License agreement expiration period			20 years	20 years